COMPANY

Singulera

Keywords: immunology cell therapy renal Kidney Transplantation

Profile checked Oct 10, 2026

Timeline

Jun 13, 2025 Trial start Phase 2: REgulatory T Cell Therapy to Achieve Immunosuppression REduction source ↗

2027-12 (ESTIMATED) · Phase 2 · REgulatory T Cell Therapy to Achieve Immunosuppression REduction · NCT06552169

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT06552169	REgulatory T Cell Therapy to Achieve Immunosuppression REduction	Phase 2	Recruiting	Jun 13, 2025	2027-12 (estimated)